Search results for "nutritional-status"

showing 3 items of 3 documents

Overview of methods used to evaluate the adequacy of nutrient intakes for individuals and populations

2009

The objective of the present paper is to review the methods of measuring micronutrient intake adequacy for individuals and for populations in order to ascertain best practice. A systematic review was conducted to locate studies on the methodological aspects of measuring nutrient adequacy. The results showed that for individuals, qualitative methods (to find probability of adequacy) and quantitative methods (to find confidence of adequacy) have been proposed for micronutrients where there is enough data to set an average nutrient requirement (ANR). If micronutrients do not have ANR, an adequate intake (AI) is often defined and can be used to assess adequacy, provided the distribution of dail…

breakfast consumptionPopulation levelDaily intakePopulationMedicine (miscellaneous)Institute of medicineEatingNutrientchildrenEnvironmental healthHumansMedicineMicronutrientsadolescentseducationVLAGHuman Nutrition & HealthGlobal Nutritiondietary-intakeWereldvoedingeducation.field_of_studyNutrition and Dieteticsbusiness.industryDietary intakeHumane Voeding & GezondheidNutritional RequirementsvitamindeterminantsNutrition SurveysMicronutrientmineral supplement useyoung-adultsDietBiotechnologyNutrition AssessmentDietary Reference Intakewomenbusinessnutritional-status
researchProduct

Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults

2020

Abstract Background In 2016, an expert working group was convened under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and formulated consensus recommendations for the conduct of clinical trials for drugs to prevent or treat sarcopenia. Aims The objective of the current paper is to provide a 2020 update of the previous recommendations in accordance with the evidence that has become available since our original recommendations. Methods This paper is based on literature reviews performed by members of the ESCEO working group and followed up with face to face meetings organized for the whole group to make amendments and discuss…

AgingSarcopeniaGeriatrics & GerontologyStandardizationDiseaseReviewRecommendationsFace-to-face0302 clinical medicineQUALITY-OF-LIFEGAIT SPEEDClinical trial; Drug registration; Guidelines; Recommendations; Sarcopenia; Treatment; Aged; Humans; Muscle Strength; Osteoarthritis; Osteoporosis; Pharmaceutical Preparations; Sarcopenia030212 general & internal medicineMUSCLE MASSDIETARY-PROTEINClinical trialPhysical limitationsPharmaceutical Preparations/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingPatient-reported outcomeGRIP STRENGTHLife Sciences & Biomedicinemedicine.medical_specialtyNUTRITIONAL-STATUSBODY-COMPOSITION030209 endocrinology & metabolismGuidelines03 medical and health sciencesClinical trial · Sarcopenia · Guidelines · Recommendations · Drug registration · TreatmentSDG 3 - Good Health and Well-beingOsteoarthritismedicineHumansMuscle StrengthDrug registrationAgedScience & Technologybusiness.industryWORKING GROUPmedicine.diseaseComorbidityClinical trialTreatmentSarcopeniaPATIENT-REPORTED OUTCOMESPhysical therapyOsteoporosisGeriatrics and GerontologyPHYSICAL PERFORMANCEbusinessAging Clinical and Experimental Research
researchProduct

Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival.

2006

Objective: To identify factors associated with tolerance and survival after noninvasive positive-pressure ventilation (NIPPV) and to investigate the influence of NIPPV on lung function in patients with ALS. Methods: NIPPV was offered to 71 patients with ALS in accordance with currently published guidelines. Effects of NIPPV on lung function and factors influencing tolerance and survival after NIPPV were studied. Results: Forty-four patients (61.9%; 95% CI: 50.6 to 73.2) tolerated NIPPV (NIPPV use >= 4 h/day) and 27 (38.1%; 95% CI: 26.8 to 49.4) were intolerant (NIPPV use = 4 h/day) and to the modifications of forced vital capacity decline after treatment initiation. The severity of bulbar i…

MaleNUTRITIONAL-STATUSmedicine.medical_specialtyVital capacityTime FactorsPositive pressureAMYOTROPHIC-LATERAL-SCLEROSISDISEASEPositive-Pressure RespirationFEV1/FVC ratioPredictive Value of TestsInternal medicineSickness Impact ProfilemedicineHumansSurvival rateLungAgedDemographyRetrospective StudiesVentilators Mechanicalbusiness.industryAmyotrophic Lateral SclerosisFUNCTIONAL RATING-SCALECAREMiddle AgedSurgeryRespiratory Function TestsSurvival RatePredictive value of testsRelative riskMultivariate AnalysisCardiologyBreathingFemaleNeurology (clinical)businessBody mass indexFollow-Up StudiesNeurology
researchProduct